Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma - Woyach, J A; Kloos, R T; Ringel, M D (J Clin Endocrinol Metab, 2009)
et al.